The global Genetically Modified Animal Model market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 269%.
This report aims to provide a comprehensive presentation of the global market for Genetically Modified Animal Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Modified Animal Model.
Report Scope
The Genetically Modified Animal Model market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetically Modified Animal Model market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetically Modified Animal Model companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
Segment by Type
Rat
Mouse
Zebrafish
Segment by Application
Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetically Modified Animal Model companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Genetically Modified Animal Model 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rat
1.2.3 Mouse
1.2.4 Zebrafish
1.3 麻豆原创 by Application
1.3.1 Global Genetically Modified Animal Model 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetically Modified Animal Model 麻豆原创 Perspective (2019-2030)
2.2 Genetically Modified Animal Model Growth Trends by Region
2.2.1 Global Genetically Modified Animal Model 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genetically Modified Animal Model Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Genetically Modified Animal Model Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Genetically Modified Animal Model 麻豆原创 Dynamics
2.3.1 Genetically Modified Animal Model Industry Trends
2.3.2 Genetically Modified Animal Model 麻豆原创 Drivers
2.3.3 Genetically Modified Animal Model 麻豆原创 Challenges
2.3.4 Genetically Modified Animal Model 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetically Modified Animal Model Players by Revenue
3.1.1 Global Top Genetically Modified Animal Model Players by Revenue (2019-2024)
3.1.2 Global Genetically Modified Animal Model Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Genetically Modified Animal Model 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetically Modified Animal Model Revenue
3.4 Global Genetically Modified Animal Model 麻豆原创 Concentration Ratio
3.4.1 Global Genetically Modified Animal Model 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetically Modified Animal Model Revenue in 2023
3.5 Genetically Modified Animal Model Key Players Head office and Area Served
3.6 Key Players Genetically Modified Animal Model Product Solution and Service
3.7 Date of Enter into Genetically Modified Animal Model 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetically Modified Animal Model Breakdown Data by Type
4.1 Global Genetically Modified Animal Model Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Genetically Modified Animal Model Forecasted 麻豆原创 Size by Type (2025-2030)
5 Genetically Modified Animal Model Breakdown Data by Application
5.1 Global Genetically Modified Animal Model Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Genetically Modified Animal Model Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Genetically Modified Animal Model 麻豆原创 Size (2019-2030)
6.2 North America Genetically Modified Animal Model 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genetically Modified Animal Model 麻豆原创 Size by Country (2019-2024)
6.4 North America Genetically Modified Animal Model 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetically Modified Animal Model 麻豆原创 Size (2019-2030)
7.2 Europe Genetically Modified Animal Model 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genetically Modified Animal Model 麻豆原创 Size by Country (2019-2024)
7.4 Europe Genetically Modified Animal Model 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetically Modified Animal Model 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Genetically Modified Animal Model 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genetically Modified Animal Model 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Genetically Modified Animal Model 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetically Modified Animal Model 麻豆原创 Size (2019-2030)
9.2 Latin America Genetically Modified Animal Model 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genetically Modified Animal Model 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Genetically Modified Animal Model 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetically Modified Animal Model 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Genetically Modified Animal Model 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genetically Modified Animal Model 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Genetically Modified Animal Model 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Model Organisms Center, Inc.
11.1.1 Shanghai Model Organisms Center, Inc. Company Detail
11.1.2 Shanghai Model Organisms Center, Inc. Business Overview
11.1.3 Shanghai Model Organisms Center, Inc. Genetically Modified Animal Model Introduction
11.1.4 Shanghai Model Organisms Center, Inc. Revenue in Genetically Modified Animal Model Business (2019-2024)
11.1.5 Shanghai Model Organisms Center, Inc. Recent Development
11.2 Gem Pharmatech Co., Ltd.
11.2.1 Gem Pharmatech Co., Ltd. Company Detail
11.2.2 Gem Pharmatech Co., Ltd. Business Overview
11.2.3 Gem Pharmatech Co., Ltd. Genetically Modified Animal Model Introduction
11.2.4 Gem Pharmatech Co., Ltd. Revenue in Genetically Modified Animal Model Business (2019-2024)
11.2.5 Gem Pharmatech Co., Ltd. Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Genetically Modified Animal Model Introduction
11.3.4 Charles River Laboratories Revenue in Genetically Modified Animal Model Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 Envigo
11.4.1 Envigo Company Detail
11.4.2 Envigo Business Overview
11.4.3 Envigo Genetically Modified Animal Model Introduction
11.4.4 Envigo Revenue in Genetically Modified Animal Model Business (2019-2024)
11.4.5 Envigo Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Detail
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Genetically Modified Animal Model Introduction
11.5.4 Taconic Biosciences Revenue in Genetically Modified Animal Model Business (2019-2024)
11.5.5 Taconic Biosciences Recent Development
11.6 Jackson Laboratory
11.6.1 Jackson Laboratory Company Detail
11.6.2 Jackson Laboratory Business Overview
11.6.3 Jackson Laboratory Genetically Modified Animal Model Introduction
11.6.4 Jackson Laboratory Revenue in Genetically Modified Animal Model Business (2019-2024)
11.6.5 Jackson Laboratory Recent Development
11.7 Shanghai SLAC
11.7.1 Shanghai SLAC Company Detail
11.7.2 Shanghai SLAC Business Overview
11.7.3 Shanghai SLAC Genetically Modified Animal Model Introduction
11.7.4 Shanghai SLAC Revenue in Genetically Modified Animal Model Business (2019-2024)
11.7.5 Shanghai SLAC Recent Development
11.8 Joinn Laboratories
11.8.1 Joinn Laboratories Company Detail
11.8.2 Joinn Laboratories Business Overview
11.8.3 Joinn Laboratories Genetically Modified Animal Model Introduction
11.8.4 Joinn Laboratories Revenue in Genetically Modified Animal Model Business (2019-2024)
11.8.5 Joinn Laboratories Recent Development
11.9 Crown Biosciences
11.9.1 Crown Biosciences Company Detail
11.9.2 Crown Biosciences Business Overview
11.9.3 Crown Biosciences Genetically Modified Animal Model Introduction
11.9.4 Crown Biosciences Revenue in Genetically Modified Animal Model Business (2019-2024)
11.9.5 Crown Biosciences Recent Development
11.10 Pharmalegacy
11.10.1 Pharmalegacy Company Detail
11.10.2 Pharmalegacy Business Overview
11.10.3 Pharmalegacy Genetically Modified Animal Model Introduction
11.10.4 Pharmalegacy Revenue in Genetically Modified Animal Model Business (2019-2024)
11.10.5 Pharmalegacy Recent Development
11.11 Syngene International
11.11.1 Syngene International Company Detail
11.11.2 Syngene International Business Overview
11.11.3 Syngene International Genetically Modified Animal Model Introduction
11.11.4 Syngene International Revenue in Genetically Modified Animal Model Business (2019-2024)
11.11.5 Syngene International Recent Development
11.12 Janvier Labs
11.12.1 Janvier Labs Company Detail
11.12.2 Janvier Labs Business Overview
11.12.3 Janvier Labs Genetically Modified Animal Model Introduction
11.12.4 Janvier Labs Revenue in Genetically Modified Animal Model Business (2019-2024)
11.12.5 Janvier Labs Recent Development
11.13 GenOway
11.13.1 GenOway Company Detail
11.13.2 GenOway Business Overview
11.13.3 GenOway Genetically Modified Animal Model Introduction
11.13.4 GenOway Revenue in Genetically Modified Animal Model Business (2019-2024)
11.13.5 GenOway Recent Development
11.14 Psychogenics
11.14.1 Psychogenics Company Detail
11.14.2 Psychogenics Business Overview
11.14.3 Psychogenics Genetically Modified Animal Model Introduction
11.14.4 Psychogenics Revenue in Genetically Modified Animal Model Business (2019-2024)
11.14.5 Psychogenics Recent Development
11.15 Horizon Discovery Group
11.15.1 Horizon Discovery Group Company Detail
11.15.2 Horizon Discovery Group Business Overview
11.15.3 Horizon Discovery Group Genetically Modified Animal Model Introduction
11.15.4 Horizon Discovery Group Revenue in Genetically Modified Animal Model Business (2019-2024)
11.15.5 Horizon Discovery Group Recent Development
11.16 Vitalstar Biotechnology
11.16.1 Vitalstar Biotechnology Company Detail
11.16.2 Vitalstar Biotechnology Business Overview
11.16.3 Vitalstar Biotechnology Genetically Modified Animal Model Introduction
11.16.4 Vitalstar Biotechnology Revenue in Genetically Modified Animal Model Business (2019-2024)
11.16.5 Vitalstar Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
听
听
*If Applicable.
